Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07383844
Recruiting Observational

Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases

NCT07383844 · tracked via the Priya Life Science France tracker
Sponsor
Fondation Lenval
Phase
Observational
Started
2026-01-21
Last updated
2026-02-03

Condition(s) studied

Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)

Investigational drug(s) / intervention(s)

IMPACT-III questionnairesData collection: CAPAS-Qsemi-structured interview

IMPACT-III questionnaires: Participants complete the self-administered questionnaires IMPACT-III)

Data collection: CAPAS-Q: Participants complete the self-administered questionnaires CAPAS-Q.

semi-structured interview: participate in a semi-structured interview about perceived barriers and facilitators to physical activity. No counseling, training, or treatment is provided.

Study summary

This study aims to identify perceived barriers and facilitators to regular physical activity among children and adolescents with inflammatory bowel disease (IBD) followed in pediatric gastroenterology. Approximately 60 participants aged 10-17 years will complete two self-administered questionnaires (CAPAS-Q for physical activity/sedentary behavior and IMPACT-III for health-related quality of life) and take part in a single semi-structured interview exploring experiences, obstacles, and levers to support sustainable physical activity. Relevant clinical data (disease characteristics, treatment and selected routine clinical parameters) will be extracted from the medical record. Participation is limited to one visit (about 45-60 minutes) during a routine hospital appointment, with no additional intervention or follow-up required.

Eligibility

Sex
ALL
Min age
10 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 10 to 17 years at inclusion. * Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months. * Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice). * Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview. * Affiliated to, or beneficiary of, a social security scheme. * no parental objection to participation (non-opposition). Exclusion Criteria: * Younger than 10 years or older than 17 years. * No IBD diagnosis, or IBD diagnosed less than 6 months ago. * Associated chronic condition (neurological, metabolic, psychiatric, or other) likely to interfere with questionnaire completion or interview participation. * Major language or cognitive impairment preventing adequate understanding or interview participation. * Not affiliated to, or not beneficiary of, a social security scheme.

Primary outcome measure(s)

  • Perceived barriers and facilitators to regular physical activity — at the inclusion
    Assessed through a single semi-structured interview. Qualitative thematic analysis will be used to identify and categorize perceived barriers and facilitators to regular physical activity in pediatric IBD.

Trial sites (1)

FacilityCityRegionStatus
Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval Nice France Recruiting

More Fondation Lenval trials in France

A Multicentre French Prospective Study of Children With Food Protein Induced Enterocolitis Syndrome in Its Acute Form Recruiting
Evertor Muscle Activity as a Predictor of Achilles Tenotomy in the Management of Idiopathic Varus Equinus Clubfoot Recruiting
Pedopsychiatric and Multidisciplinary Research Devoted to Children Exposed to the Attack in Nice on July 14, 2016 Active, not recruiting
Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children. Recruiting
Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07383844 on ClinicalTrials.gov ↗ ← All trials in France